Effectiveness of the first French psychoeducational program on unipolar depression: study protocol for a randomized controlled trial

Déborah Ducasse, Philippe Courtet, Maude Sénèque, Catherine Genty, Marie-Christine Picot, Raymund Schwan, Emilie Olié, Déborah Ducasse, Philippe Courtet, Maude Sénèque, Catherine Genty, Marie-Christine Picot, Raymund Schwan, Emilie Olié

Abstract

Background: Major Depressive Disorder (MDD) is highly prevalent and was associated with greater morbidity, mortality (including suicide), and healthcare costs. By 2030, MDD will become the leading cause of disability in high-income countries. Notably, among patients with a previous experience of a major depressive episode, it was indeed estimated that up to 85 % of those patients will suffer from relapse. Two main factors were associated with a significantly higher risk of relapse: poor medication adherence and low self-efficacy in disease management. Interestingly, these issues could become the targets of psychoeducational programs for chronic diseases. Indded psychoeducational program for depression are recommended in international guidelines, but have not yet been proposed in France.

Methods/design: We propose to evaluate the first French psychoeducational program for depression "ENVIE" in a multicenter randomized controlled trial. The group intervention will include 9 weekly sessions. Its aim is to educate patients on the latest knowledge on depression and effective treatments through didactic and interactive sessions. Patients will experiment the latest innovating psychological skills (from acceptance and commitment therapy) to cope with depressive symptoms and maintain motivation in behavioral activation. In total, 332 unipolar non-chronic (<2 years) outpatients with moderate to severe depression, without psychotic features, will be randomly allocated to the add-on ENVIE program (N = 166) or to a waiting list (N = 166). The follow-up will last 15 months and include 5 assessment visits. The primary endpoint will be the remission rate of the index episode at 15 months post-inclusion, defined by a Montgomery and Asberg Depression Rating Scale (MADRS) score ≤ 12 over an 8-week period, and without relapse during follow-up. We will also assess the response rate and relapse at 15 months post-inclusion, hospitalization rate and adherence to treatment during the follow-up period, quality of life and global functioning upon inclusion and at 9 and 15 months post inclusion.

Discussion: If the proposed trial shows the effectiveness of the intervention, but also an increased remission rate in depressed outpatients at 15-months post-inclusion, in addition to improved treatment adherence in patients, it will further promotes arguments in favor of a wide dissemination of psychoeducational programs for depression.

Trial registration: This trial is registered under number 2015-A00249-40 (PURE clinical trial: NCT02501226 ) (June 30th, 2015).

Trial registration: ClinicalTrials.gov NCT00319540 NCT02501226.

Figures

Fig. 1
Fig. 1
Study flow

References

    1. Gopinath S, Katon WJ, Russo JE, Ludman EJ. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. J Affect Disord. 2007;101:57–63. doi: 10.1016/j.jad.2006.10.023.
    1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–86. doi: 10.1016/S0140-6736(13)61611-6.
    1. Katon W, Lin E, Russo J, Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60:897–903. doi: 10.1001/archpsyc.60.9.897.
    1. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A. Excess costs of common mental disorders: population-based cohort study. J Ment Health Policy Econ. 2006;9:193–200.
    1. Simon GE, Chisholm D, Treglia M, Bushnell D, Group L. Course of depression, health services costs, and work productivity in an international primary care study. Gen Hosp Psychiatry. 2002;24:328–35. doi: 10.1016/S0163-8343(02)00201-3.
    1. Simon GE, Von Korff M, Ludman EJ, Katon WJ, Rutter C, Unutzer J, et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Med Care. 2002;40:941–50. doi: 10.1097/00005650-200210000-00011.
    1. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. doi: 10.1176/appi.ajp.163.1.28.
    1. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand. 2010;122:184–91. doi: 10.1111/j.1600-0447.2009.01519.x.
    1. Linhorst DM, Hamilton G, Young E, Eckert A. Opportunities and barriers to empowering people with severe mental illness through participation in treatment planning. Soc Work. 2002;47:425–34. doi: 10.1093/sw/47.4.425.
    1. Colom F. Keeping therapies simple: psychoeducation in the prevention of relapse in affective disorders. Br J Psychiatry. 2011;198:338–40. doi: 10.1192/bjp.bp.110.090209.
    1. Excellence NIfHC. NICE guidelines for Mental Health & Behavioral conditions. 2010 [cited; Available from:
    1. Preventive Services Task Force Screening for depression in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:784–92. doi: 10.7326/0003-4819-151-11-200912010-00006.
    1. American Psychiatric Association . Practice guideline for the treatment of patients with major depressive disorder. 3. Arlington (VA): American Psychiatric Association (APA); 2010.
    1. Scogin F, Jamison C, Gochneaur K. Comparative efficacy of cognitive and behavioral bibliotherapy for mildly and moderately depressed older adults. J Consult Clin Psychol. 1989;57:403–7. doi: 10.1037/0022-006X.57.3.403.
    1. Jamison C, Scogin F. The outcome of cognitive bibliotherapy with depressed adults. J Consult Clin Psychol. 1995;63:644–50. doi: 10.1037/0022-006X.63.4.644.
    1. Dowrick C, Dunn G, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V, et al. Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. Outcomes of Depression International Network (ODIN) Group. BMJ. 2000;321:1450–4. doi: 10.1136/bmj.321.7274.1450.
    1. Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241–7. doi: 10.1001/archpsyc.58.3.241.
    1. Von Korff M, Katon W, Rutter C, Ludman E, Simon G, Lin E, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med. 2003;65:938–43. doi: 10.1097/01.PSY.0000097336.95046.0C.
    1. Brown JS, Elliott SA, Boardman J, Ferns J, Morrison J. Meeting the unmet need for depression services with psycho-educational self-confidence workshops: preliminary report. Br J Psychiatry. 2004;185:511–5. doi: 10.1192/bjp.185.6.511.
    1. Clarke G, Eubanks D, Reid E, Kelleher C, O’Connor E, DeBar L. Overcoming depression on the Internet (ODIN) (2): a randomized trial of a self-help depression skills program with reminders. J Med Internet Res. 2005;7:2. doi: 10.2196/jmir.7.2.e16.
    1. Clarke G, Reid E, Eubanks D, O’Connor E, deBar L, Kelleher C. Overcoming depression on the Internet (ODIN): a randomised controlled trial of an Internet depression skills intervention program. J Med Internet Res. 2002;4:e14. doi: 10.2196/jmir.4.3.e14.
    1. Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression by using the internet: randomised controlled trial. BMJ. 2004;328:265. doi: 10.1136/.
    1. Dalgard OS. A randomized controlled trial of a psychoeducational group program for unipolar depression in adults in Norway (NCT00319540) Clin Pract Epidemiol Ment Health. 2006;2:15. doi: 10.1186/1745-0179-2-15.
    1. Butler LD, Waelde LC, Hastings TA, Chen XH, Symons B, Marshall J, et al. Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial. J Clin Psychol. 2008;64:806–20. doi: 10.1002/jclp.20496.
    1. Hansson M, Bodlund O, Chotai J. Patient education and group counselling to improve the treatment of depression in primary care: a randomized controlled trial. J Affect Disord. 2008;105:235–40. doi: 10.1016/j.jad.2007.04.007.
    1. Cuijpers P, Munoz RF, Clarke GN, Lewinsohn PM. Psychoeducational treatment and prevention of depression: the “Coping with Depression” course thirty years later. Clin Psychol Rev. 2009;29:449–58. doi: 10.1016/j.cpr.2009.04.005.
    1. Donker T, Griffiths KM, Cuijpers P, Christensen H. Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC Med. 2009;7:79. doi: 10.1186/1741-7015-7-79.
    1. Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M. Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. J Med Internet Res. 2009;11:e15. doi: 10.2196/jmir.1151.
    1. Casanas R, Catalan R, del Val JL, Real J, Valero S, Casas M. Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial. BMC Psychiatry. 2012;12:230. doi: 10.1186/1471-244X-12-230.
    1. Shimazu K, Shimodera S, Mino Y, Nishida A, Kamimura N, Sawada K, et al. Family psychoeducation for major depression: randomised controlled trial. Br J Psychiatry. 2011;198:385–90. doi: 10.1192/bjp.bp.110.078626.
    1. Shimodera S, Furukawa TA, Mino Y, Shimazu K, Nishida A, Inoue S. Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial. BMC Psychiatry. 2012;12:40. doi: 10.1186/1471-244X-12-40.
    1. Morokuma I, Shimodera S, Fujita H, Hashizume H, Kamimura N, Kawamura A, et al. Psychoeducation for major depressive disorders: a randomised controlled trial. Psychiatry Res. 2013;210:134–9. doi: 10.1016/j.psychres.2013.05.018.
    1. Stangier U, Hilling C, Heidenreich T, Risch AK, Barocka A, Schlosser R, et al. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial. Am J Psychiatry. 2013;170:624–32. doi: 10.1176/appi.ajp.2013.12060734.
    1. Seedat S, Haskis A, Stein DJ. Benefits of consumer psychoeducation: a pilot program in South Africa. Int J Psychiatry Med. 2008;38:31–42. doi: 10.2190/PM.38.1.c.
    1. Cuijpers P. Bibliotherapy in unipolar depression: a meta-analysis. J Behav Ther Exp Psychiatry. 1997;28:139–47. doi: 10.1016/S0005-7916(97)00005-0.
    1. Teri L, Lewinsohn PM. Individual and group treatment of unipolar depression: comparison of treatment outcome and identification of predictors of successful treatment outcome. Behav Ther. 1986;17:215–28. doi: 10.1016/S0005-7894(86)80052-1.
    1. Simon GE, Katon WJ, VonKorff M, Unutzer J, Lin EH, Walker EA, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158:1638–44. doi: 10.1176/appi.ajp.158.10.1638.
    1. Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry. 2001;58:181–7. doi: 10.1001/archpsyc.58.2.181.
    1. Hollon SD, Ponniah K. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety. 2010;27:891–932. doi: 10.1002/da.20741.
    1. Bohlmeijer ET, Fledderus M, Rokx TA, Pieterse ME. Efficacy of an early intervention based on acceptance and commitment therapy for adults with depressive symptomatology: Evaluation in a randomized controlled trial. Behav Res Ther. 2011;49:62–7. doi: 10.1016/j.brat.2010.10.003.
    1. National action alliance for suicide prevention. .
    1. Forman EM, Herbert JD, Moitra E, Yeomans PD, Geller PA. A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depression. Behav Modif. 2007;31:772–99. doi: 10.1177/0145445507302202.
    1. Zettle RD, Rains JC, Hayes SC. Processes of change in acceptance and commitment therapy and cognitive therapy for depression: a mediation reanalysis of Zettle and Rains. Behav Modif. 2011;35:265–83. doi: 10.1177/0145445511398344.
    1. Zettle RD, Hayes SC. Dysfunctional control by client verbal behavior: the context of reason-giving. Anal Verbal Behav. 1986;4:30–8.
    1. Zettle RD, Rains JC. Group cognitive and contextual therapies in treatment of depression. J Clin Psychol. 1989;45:436–45. doi: 10.1002/1097-4679(198905)45:3<436::AID-JCLP2270450314>;2-L.
    1. Luoma JB, Villatte JL. Mindfulness in the treatment of suicidal individuals. Cogn Behav Pract. 2012;19:265–76. doi: 10.1016/j.cbpra.2010.12.003.
    1. Ducasse D, René E, Béziat S, Guillaume S, Courtet P, Olie E. Acceptance and commitment therapy for management of suicidal patients: a pilot study. Psychother Psychosom. 2014: In Press.
    1. Vuorilehto MS, Melartin TK, Isometsa ET. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med. 2009;39:1697–707. doi: 10.1017/S0033291709005182.
    1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511. doi: 10.1161/01.CIR.0000052939.59093.45.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic interview for DSM-IV and CIM-10. J Clin Psychiatry. 1998;59:22–3.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM5). 2013.
    1. Klengel T, Binder EB. Gene-environment interactions in major depressive disorder. Can J Psychiatry. 2013;58:76–83.
    1. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379:1045–55. doi: 10.1016/S0140-6736(11)60602-8.
    1. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010;167:509–27. doi: 10.1176/appi.ajp.2010.09101452.
    1. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157:115–8. doi: 10.1176/ajp.157.1.115.
    1. Bremner JD. Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectr. 2002;7:129–30.
    1. Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications Cambridge University Press. 4 2013.
    1. Schoendorff B. La thérapie d’acceptation et d’engagement: guide clinique. Bruxelles: De Boeck ed; 2011.
    1. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266–77. doi: 10.1176/appi.ajp.2011.10111704.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9. doi: 10.1192/bjp.134.4.382.
    1. Beck AT. Beck Depression Inventory. 2. San Antonio: The Psychological Corporation ed; 1996.
    1. Rosa AR, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5. doi: 10.1186/1745-0179-3-5.
    1. Murphy B, Herman H, Hawthorne G, Pinzone T, Evert H. Australian WHOQoL instruments: User’s manual and interpretation guide. Melbourne: Australian WHOQoL Field Study Centre ed; 2000.
    1. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241–7. doi: 10.1016/S0920-9964(99)00130-9.
    1. Hackett RA, Hamer M, Endrighi R, Brydon L, Steptoe A. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology. 2012;37:1801–9. doi: 10.1016/j.psyneuen.2012.03.016.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera